{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:55:52Z","timestamp":1767135352283,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":146,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003620.pub2","type":"reference-entry","created":{"date-parts":[[2005,4,22]],"date-time":"2005-04-22T10:35:41Z","timestamp":1114166141000},"source":"Crossref","is-referenced-by-count":15,"title":["Milk thistle for alcoholic and\/or hepatitis B or C virus liver diseases"],"prefix":"10.1002","author":[{"given":"A","family":"Rambaldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BP","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Iaquinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,4,20]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD003620.pub2-BIB1|cit1","first-page":"1370","article-title":"Effects of silymarin on alcoholic liver disease. A controlled trial","volume":"120","author":"Bunout","year":"1992","journal-title":"Revista M\u00e9dica de Chile"},{"issue":"9","key":"10.1002\/14651858.CD003620.pub2-BIB2|cit2","first-page":"456","article-title":"A pilot study on the liver protective effect of silybinphosphatidylcholine complex (IdB1016) in chronic active hepatitis","volume":"31","author":"Buzzelli","year":"1993","journal-title":"International Journal of Clinical Pharmacology, Therapy and Toxicology"},{"issue":"1","key":"10.1002\/14651858.CD003620.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0011-393X(05)80160-2","article-title":"Therapeutic and antilipoperoxidant effects of silybin-phosphatidylcholine complex in chronic liver disease: preliminary results","volume":"53","author":"Moscarella","year":"1993","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003620.pub2-BIB4|cit4","first-page":"S100","article-title":"Therapeutic effect of Silipide\u00ae in patients with chronic hepatitis C non-responders (NRs) to interferon (IFN) treatment [abstract]","volume":"21","author":"Buzzelli","year":"1994","journal-title":"Journal of Hepatology"},{"issue":"24","key":"10.1002\/14651858.CD003620.pub2-BIB7|cit5","first-page":"1291","article-title":"Immunomodulatory effects of silymarin treatment in chronic alcoholic liver disease","volume":"131","author":"De\u00e1k","year":"1990","journal-title":"Orvosi Hetilap"},{"key":"10.1002\/14651858.CD003620.pub2-BIB5|cit6","first-page":"2723","article-title":"Hepatoprotective activity of silymarin (Legalon\u00ae) therapy in patients with chronic alcoholic liver disease","volume":"130","author":"Feh\u00e9r","year":"1989","journal-title":"Orvosi Hetilap"},{"key":"10.1002\/14651858.CD003620.pub2-BIB8|cit7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/003655298750026543","article-title":"Oxidative stress in the liver and biliary tract diseases","volume":"228","author":"Feh\u00e9r","year":"1998","journal-title":"Scandinavian Journal of Gastroenterology Supplements"},{"issue":"16","key":"10.1002\/14651858.CD003620.pub2-BIB6|cit8","first-page":"863","article-title":"Effects of silymarin (Legalon\u00ae) treatment on the antioxidant defense system and lipid peroxidation in patients with chronic alcoholic liver disease. A double blind study","volume":"131","author":"M\u00fczes","year":"1990","journal-title":"Orvosi Hetilap"},{"issue":"19","key":"10.1002\/14651858.CD003620.pub2-BIB12|cit9","first-page":"678","article-title":"The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis","volume":"92","author":"Benda","year":"1980","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB11|cit10","first-page":"790","article-title":"Treatment with silymarin in patients with cirrhosis of the liver - results of a controlled prospective study and of the post study surveillance [abstract]","volume":"6","author":"Ferenci","year":"1986","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB9|cit11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0168-8278(89)90083-4","article-title":"Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver","volume":"9","author":"Ferenci","year":"1989","journal-title":"Journal of Hepatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003620.pub2-BIB10|cit12","first-page":"S229","article-title":"Controlled prospective study on the effects of silymarin-treatment on patients with cirrhosis of the liver [abstract]","volume":"1","author":"Ferenci","year":"1985","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB13|cit13","first-page":"5589","article-title":"Proof of therapeutic effect of Legalon\u00ae for toxic liver diseases in a double blind trial","volume":"30","author":"Fintelmann","year":"1980","journal-title":"Therapiewoche"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB14|cit14","first-page":"222","article-title":"Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent","volume":"15","author":"Lirussi","year":"2002","journal-title":"Diabetes, Nutrition & Metabolism - Clinical & Experimental"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB15|cit15","first-page":"629A","article-title":"Effects of silymarin on the oxidative stress in patients with alcoholic liver cirrhosis. Results from a controlled, double blind, randomized pilot clinical trial [abstract]","volume":"28","author":"Andrade","year":"1998","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003620.pub2-BIB16|cit16","first-page":"150","article-title":"Antioxidants effects of silymarin MZ80 in patients with alcoholic liver cirrhosis: results from a randomized, placebo-controlled, double-blind, clinical trial [abstract]","volume":"30","author":"Andrade","year":"1999","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD003620.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5414\/CPP40002","article-title":"Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study","volume":"40","author":"Lucena","year":"2002","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"issue":"2,3","key":"10.1002\/14651858.CD003620.pub2-BIB21|cit18","first-page":"129","article-title":"In vivo effect of free radical scavenger hepatoprotective agents on superoxide dismutase (SOD) activity in patients","volume":"15","author":"Feh\u00e9r","year":"1990","journal-title":"The Tokai Journal of Experimental and Clinical Medicine"},{"issue":"3-4","key":"10.1002\/14651858.CD003620.pub2-BIB19|cit19","first-page":"287","article-title":"Hepatoprotective and immunomodulatory effects of antioxidant therapy","volume":"45","author":"L\u00e1ng","year":"1988","journal-title":"Acta Medica Hungarica"},{"key":"10.1002\/14651858.CD003620.pub2-BIB18|cit20","first-page":"283","article-title":"Immunomodulatory and hepatoprotective effects of in vivo treatment with free radical scavengers","volume":"22","author":"L\u00e1ng","year":"1990","journal-title":"Italian Journal of Gastroenterology"},{"issue":"2-3","key":"10.1002\/14651858.CD003620.pub2-BIB20|cit21","first-page":"123","article-title":"Hepatoprotective and immunological effects of antioxidant drugs","volume":"15","author":"L\u00e1ng","year":"1990","journal-title":"The Tokai Journal of Experimental and Clinical Medicine"},{"issue":"28\/29","key":"10.1002\/14651858.CD003620.pub2-BIB22|cit22","first-page":"1060","article-title":"Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres","volume":"73","author":"Magliulo","year":"1978","journal-title":"Medizinsche Klinik"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0168-8278(98)80285-7","article-title":"Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial","volume":"28","author":"Par\u00e9s","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/00365528209182242","article-title":"Effect of silymarinon on chemical, functional, and morhological alterations of the liver: a double blind controlled study","volume":"17","author":"Salmi","year":"1982","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB25|cit25","first-page":"S124","article-title":"Silymarin treatment in alcoholic liver disease: a double blind randomized clinical trial (RCT) [abstract]","volume":"Suppl 1","author":"Salvagnini","year":"1985","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD003620.pub2-BIB26|cit26","first-page":"120","article-title":"A randomized double blind trial of silymarin in 116 patients with alcoholic hepatitis","volume":"13","author":"Trinchet","year":"1989","journal-title":"Gastroenterologie Clinique et Biologique"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0168-8278(97)80255-3","article-title":"Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients","volume":"26","author":"Velussi","year":"1997","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD003620.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0011-393X(05)80660-5","article-title":"Silymarin reduces hyperinsulinemia, malondialdehyde levels, and daily insulin need in cirrhotic diabetic patients","volume":"53","author":"Velussi","year":"1993","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"3","key":"10.1002\/14651858.CD003620.pub2-BIB29|cit29","first-page":"512","article-title":"Silymarin in liver cirrhosis","volume":"123","author":"Benda","year":"1973","journal-title":"Wiener Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD003620.pub2-BIB30|cit30","first-page":"240","article-title":"Double blind trial of silymarin versus placebo in the treatment of chronic hepatitis","volume":"119","author":"Berenguer","year":"1977","journal-title":"M\u00fcnchener Medizinische Wochenschrift"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003620.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF03042201","article-title":"A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories","volume":"94","author":"Berkson","year":"1999","journal-title":"Medizinische Klinik"},{"issue":"12","key":"10.1002\/14651858.CD003620.pub2-BIB32|cit32","first-page":"513","article-title":"Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial","volume":"72","author":"Bode","year":"1977","journal-title":"Medizinische Klinik"},{"key":"10.1002\/14651858.CD003620.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/978-3-642-85452-1_159","article-title":"Therapy of acute virus hepatitis with silymarin. Report of a controlled study","volume":"83","author":"Schmidt","year":"1977","journal-title":"Verhandlungen der Deutschen Gesellschaft fur Innere Medizin"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB34|cit34","first-page":"307","article-title":"Use of silymarin in the treatment of alcoholic hepatic steatosis","volume":"114","author":"Canini","year":"1985","journal-title":"La Clinica Terapeutica"},{"key":"10.1002\/14651858.CD003620.pub2-BIB35|cit35","first-page":"628","article-title":"A controlled clinical trial of Legalon\u00ae in 40 patients","volume":"133","author":"Cavalieri","year":"1974","journal-title":"Gazzetta Medica Italiana"},{"key":"10.1002\/14651858.CD003620.pub2-BIB36|cit36","series-title":"3rd International Symposium on Flavonoids in Biology and Medicine","first-page":"P29","article-title":"Liver protective activity of IdB1016, a new flavanolignan complex [abstract]","author":"Conti","year":"1989"},{"key":"10.1002\/14651858.CD003620.pub2-BIB37|cit37","first-page":"135","article-title":"Relationship between changes in lipid metabolism and macrocytic anemia in chronic liver disease. Evaluation of therapy with a membranotropic drug","volume":"111","author":"Martiis","year":"1984","journal-title":"La Clinica Terapeutica"},{"issue":"3","key":"10.1002\/14651858.CD003620.pub2-BIB39|cit38","first-page":"283","article-title":"Milk thistle (Silybin marianum) derivatives in the therapy of chronic hepatopathies","volume":"94","author":"Martiis","year":"1980","journal-title":"La Clinica Terapeutica"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB38|cit39","first-page":"333","article-title":"Silymarin, a membranotropic drug: clinical and experimental observations","volume":"81","author":"Martiis","year":"1977","journal-title":"La Clinica Terapeutica"},{"key":"10.1002\/14651858.CD003620.pub2-BIB40|cit40","unstructured":"Dittrich M Double-blind study for the therapy of liver cirrhosis Drug-Symposium Legalon, XI International Congress of Gastroenterology. Hamburg 1980"},{"key":"10.1002\/14651858.CD003620.pub2-BIB41|cit41","first-page":"865","article-title":"Silymarin and some problems of present therapy of chronic hepatopathies","volume":"112","author":"Fassati","year":"1973","journal-title":"Casopis L\u00e9kasy Ceskych"},{"issue":"6","key":"10.1002\/14651858.CD003620.pub2-BIB43|cit42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/10715768709088078","article-title":"Effect of silibinin on the activity and expression of superoxide dismutase in lymphocytes from patients with alcoholic liver disease","volume":"3","author":"Feh\u00e9r","year":"1987","journal-title":"Free Radical Research Communications"},{"issue":"3-4","key":"10.1002\/14651858.CD003620.pub2-BIB42|cit43","first-page":"265","article-title":"Effect of free radical scavengers on superoxide dismutase (SOD) enzyme in patients with alcoholic cirrhosis","volume":"45","author":"Feh\u00e9r","year":"1988","journal-title":"Acta Medica Hungarica"},{"key":"10.1002\/14651858.CD003620.pub2-BIB44|cit44","first-page":"1055","article-title":"About silymarin therapy for fatty liver","volume":"23","author":"Fintelmann","year":"1970","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD003620.pub2-BIB45|cit45","first-page":"5589","article-title":"Proof of therapeutic effect of Legalon\u00ae for toxic liver diseases in a double blind trial","volume":"30","author":"Fintelmann","year":"1980","journal-title":"Therapiewoche"},{"issue":"17","key":"10.1002\/14651858.CD003620.pub2-BIB46|cit46","first-page":"1419","article-title":"Effect of misoprostol on the course of viral hepatitis B","volume":"44","author":"Flisiak","year":"1997","journal-title":"Hepato-Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD003620.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00042737-199911000-00007","article-title":"Effect of misoprostol on serum beta2-microglobulin in the course of viral hepatitis B","volume":"11","author":"Flisiak","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"4-6","key":"10.1002\/14651858.CD003620.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0090-6980(99)00059-3","article-title":"One year follow-up of patients treated with misoprostol in acute phase of viral hepatitis B","volume":"60","author":"Flisiak","year":"2000","journal-title":"Prostaglandins and other Lipid Mediators"},{"issue":"36","key":"10.1002\/14651858.CD003620.pub2-BIB49|cit49","first-page":"1204","article-title":"On the objective assessment of silymarin action in liver diseases","volume":"66","author":"Hammerl","year":"1971","journal-title":"Medizinsche Klinik"},{"issue":"4 Pt2","key":"10.1002\/14651858.CD003620.pub2-BIB50|cit50","first-page":"590A","article-title":"Possible deleterious effects of milk thistle on anti-viral therapy for chronic hepatitis C [abstract]","volume":"36","author":"Ippolito","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD003620.pub2-BIB51|cit51","first-page":"318","article-title":"Results of two double-blind studies on the effect of silymarine in chronic hepatitis","volume":"7","author":"Kiesewetter","year":"1977","journal-title":"Leber Magen Darm"},{"issue":"45","key":"10.1002\/14651858.CD003620.pub2-BIB52|cit52","first-page":"1406","article-title":"Therapeutic effect of silymarin in patients with cirrhosis of the liver","volume":"126","author":"Kupcov\u00e1","year":"1987","journal-title":"Casopis L\u00e9kasy Ceskych"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003620.pub2-BIB54|cit53","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/0168-8278(90)91723-A","article-title":"Silymarin (sily) vs ursodeoxycholic acid (UDCA) in active cirrhosis: a controlled cross-over study [abstract]","volume":"11","author":"Lirussi","year":"1990","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB56|cit54","first-page":"31","article-title":"Treatment of active cirrhosis with ursodeoxycholic acid and a free scavenger: a two year prospective study","volume":"23","author":"Lirussi","year":"1995","journal-title":"Medical Science Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003620.pub2-BIB53|cit55","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1016\/0168-8278(89)90543-6","article-title":"Effect of UDCA and silymarin on liver function in patients with chronic active hepatitis with cirrhosis: a prospective study [abstract]","volume":"9","author":"Lirussi","year":"1989","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB55|cit56","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0168-8278(91)90829-Z","article-title":"Effect of silibilin on biliary lipid composition. Experimental and clinical study","volume":"12","author":"Nassuato","year":"1991","journal-title":"Journal of Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD003620.pub2-BIB57|cit57","first-page":"74","article-title":"Antioxidant activity of hepatotropic preparations in the treatment of chronic diseases of the liver","volume":"60","author":"Loginov","year":"1988","journal-title":"Terapeuticeskij Archiv"},{"issue":"12","key":"10.1002\/14651858.CD003620.pub2-BIB58|cit58","first-page":"1768","article-title":"Silymarin in chronic liver diseases","volume":"111","author":"Muscher","year":"1972","journal-title":"Therapeutische Erfahrungen"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD003620.pub2-BIB59|cit59","first-page":"191A","article-title":"A survey of the use of herbal medicine in patients with hepatitis C","volume":"30","author":"Peyton","year":"1999","journal-title":"Hepatology"},{"issue":"30","key":"10.1002\/14651858.CD003620.pub2-BIB60|cit60","first-page":"1655","article-title":"Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C","volume":"141","author":"P\u00e1r","year":"2000","journal-title":"Orvosi Hetilap"},{"issue":"19","key":"10.1002\/14651858.CD003620.pub2-BIB61|cit61","first-page":"595","article-title":"Clinical investigation of silymarin in chronic liver diseases","volume":"64","author":"Realini","year":"1975","journal-title":"Schweizerische Rundschau fur Medizin Praxis"},{"issue":"36","key":"10.1002\/14651858.CD003620.pub2-BIB62|cit62","first-page":"1145","article-title":"Clinical experience with silymarin for chronic liver disease","volume":"64","author":"Reutter","year":"1975","journal-title":"Schweizerische Rundschau fur Medizin Praxis"},{"issue":"5","key":"10.1002\/14651858.CD003620.pub2-BIB63|cit63","first-page":"277","article-title":"Efficacy of silymarin treatment for acute viral hepatitis","volume":"25","author":"Saba","year":"1979","journal-title":"Epatologia"},{"key":"10.1002\/14651858.CD003620.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/00365528209182242","article-title":"Effect of silymarinon on chemical, functional, and morphological alterations of the liver: a double blind controlled study","volume":"17","author":"Salmi","year":"1982","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB65|cit65","series-title":"Aktuelle Hepatologie. 3rd International Symposium, Cologne","first-page":"42","article-title":"Therapy of liver diseases with Legalon\u00ae: a controlled double-blind study","author":"Varis"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB66|cit66","first-page":"445","article-title":"Sylimarine in the treatment of chronic hepatitis","volume":"31","author":"Sawaryn","year":"1977","journal-title":"Przegla epidemiologiczny"},{"key":"10.1002\/14651858.CD003620.pub2-BIB67|cit67","first-page":"691","article-title":"Further observations on the therapy of hepatoses. Therapeutic use of silymarin","volume":"15","author":"Schopen","year":"1970","journal-title":"Die Medizinische Welt"},{"key":"10.1002\/14651858.CD003620.pub2-BIB68|cit68","first-page":"577","article-title":"Influence of Legalon\u00ae 140 on the metabolism of collagen in patients with chronic liver disease - review by measurement of PIIINP-values","volume":"74","author":"Schuppan","year":"1998","journal-title":"Zeitschrift f\u00fcr Allgemeinmedizin"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB69|cit69","first-page":"311","article-title":"Use of the Romanian product Silimarina\u00ae in the treatment of chronic liver diseases","volume":"26","author":"Tanasescu","year":"1988","journal-title":"Medecine Interne"},{"key":"10.1002\/14651858.CD003620.pub2-BIB70|cit70","first-page":"613","article-title":"Sylimarol in the treatment of acute viral hepatitis","volume":"36","author":"Tkacz","year":"1983","journal-title":"Wiadomosci Lekarskie"},{"issue":"3","key":"10.1002\/14651858.CD003620.pub2-BIB71|cit71","first-page":"219","article-title":"Randomized open study of the dose-effect relationship of a short course of IdB in 1016 in patients with viral or alcoholic hepatitis","volume":"64","author":"Vailati","year":"1993","journal-title":"Fitoterapia"},{"issue":"6","key":"10.1002\/14651858.CD003620.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/0006-2952(77)90449-X","article-title":"Inhibitory action of silymarin of lipid peroxide formation in rat liver mithochondria and microsomes","volume":"26","author":"Bindoli","year":"1977","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003620.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0168-8278(88)80005-9","article-title":"Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis","volume":"28","author":"Bird","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/hep.510260316","article-title":"Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats","volume":"26","author":"Boigk","year":"1997","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB76|cit76","doi-asserted-by":"crossref","unstructured":"Brok J Gluud LL Gluud C Ribavirin plus interferon versus interferon for chronic hepatitis C The Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD005445. DOI: 10.1002\/14651858.CD005445","DOI":"10.1002\/14651858.CD005445"},{"key":"10.1002\/14651858.CD003620.pub2-BIB77|cit77","doi-asserted-by":"crossref","unstructured":"Brok J Gluud LL Gluud C Ribavirin monotherapy for chronic hepatitis C The Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD005527. DOI: 10.1002\/14651858.CD005527","DOI":"10.1002\/14651858.CD005527"},{"issue":"5","key":"10.1002\/14651858.CD003620.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-2006-962055","article-title":"Silybin dihemisuccinate protects against glutathione depletion and lipid peroxidation induced by acetamiophen on rat liver","volume":"55","author":"Campos","year":"1989","journal-title":"Planta Medica"},{"issue":"2","key":"10.1002\/14651858.CD003620.pub2-BIB79|cit79","first-page":"128","article-title":"Hepatitis B and hepatitis C virus infection among chronic alcoholic patients with liver disease in Taiwan","volume":"93","author":"Chang","year":"1994","journal-title":"Journal of Formosan Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD003620.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.37.1.113","article-title":"Glucocorticoids are ineffective in alcoholic hepatitis","volume":"37","author":"Christensen","year":"1995","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0168-8278(98)80284-5","article-title":"Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy","volume":"28","author":"Corrao","year":"1998","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.510270404","article-title":"Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis","volume":"27","author":"Corrao","year":"1998","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/he.2000.5789","article-title":"Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage","volume":"31","author":"Franceschi","year":"2000","journal-title":"Hepatology"},{"issue":"7","key":"10.1002\/14651858.CD003620.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/sim.4780060706","article-title":"Practical aspects in monitoring: a brief review","volume":"6","author":"Demets","year":"1987","journal-title":"Statisctics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003620.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD003620.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.1840360716","article-title":"Optimal therapy of hepatitis C","volume":"36","author":"Bisceglie","year":"2002","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003620.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0041-008X(78)90091-1","article-title":"Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides","volume":"46","author":"Floersheim","year":"1978","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003620.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1572-0241.1998.00139.x","article-title":"Milk thistle (Silybum marianum) for the therapy of liver disease","volume":"93","author":"Flora","year":"1998","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB90|cit90","first-page":"S387","article-title":"Anaphylactic shock due to an extract of Silybum marianum in a patient with immediate-type allergy to kiwi fruit","volume":"10","author":"Geier","year":"1990","journal-title":"Allergologie"},{"issue":"6","key":"10.1002\/14651858.CD003620.pub2-BIB91|cit91","first-page":"564","article-title":"Testosterone and alcoholic cirrhosis. Epidemiologic, pathophyphysiologic and therapeutic studies in men","volume":"35","author":"Gluud","year":"1988","journal-title":"Danish Medical Bullettin"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB92|cit92","first-page":"221","article-title":"Diagnosis and treatment of alcoholic liver disease in Europe","volume":"6","author":"Gluud","year":"1993","journal-title":"Gastroenterology International"},{"key":"10.1002\/14651858.CD003620.pub2-BIB93|cit93","series-title":"Falk Symposium 121. Steatosis (NASH and ASH)","first-page":"322","article-title":"Alcoholic hepatitis: no glucocorticosteroids?","author":"Gluud","year":"2001"},{"key":"10.1002\/14651858.CD003620.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0168-8278(02)00312-4","article-title":"Acute, serious drug-induced liver injury","volume":"37","author":"Gluud","year":"2002","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB95|cit95","unstructured":"Gluud C Als-Nielsen B D'Amico G Gluud LL Khan S Klingenberg SL Hepato-Biliary Group About The Cochrane Collaboration (Collaborative Review Groups (CRGs))"},{"key":"10.1002\/14651858.CD003620.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.2042-7158.1993.tb05619.x","article-title":"The effect of silymarin and gamma radiation on nucleid acids in rat organs","volume":"45","author":"Hakova","year":"1993","journal-title":"The Journal of Pharmacy and Pharmacology"},{"issue":"Pt 6","key":"10.1002\/14651858.CD003620.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/000456329703400610","article-title":"Biochemical effect of antioxidants on lipids and liver function in experimentally-induced liver damage","volume":"34","author":"Halim","year":"1997","journal-title":"Annals of Clinical Biochemistry"},{"issue":"7414","key":"10.1002\/14651858.CD003620.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003620.pub2-BIB99|cit99","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] The Cochrane Library, Issue 3, 2005 Chichester, UK John Wiley & sons, Ltd"},{"key":"10.1002\/14651858.CD003620.pub2-BIB100|cit100","volume-title":"Code of Federal Regulations & Guidelines","volume":"1","year":"1997"},{"key":"10.1002\/14651858.CD003620.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.286.7.821","article-title":"Comparison of evidence of treatment effects in randomized and nonrandomized studies","volume":"286","author":"Ioannidis","year":"2001","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD003620.pub2-BIB102|cit102","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(02)01244-5","article-title":"Milk thistle for the treatment of liver disease: a systematic review and meta-analysis","volume":"113","author":"Jacobs","year":"2002","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003620.pub2-BIB103|cit103","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003620.pub2-BIB104|cit104","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.289.2.217","article-title":"Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review","volume":"289","author":"Kjaergard","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003620.pub2-BIB105|cit105","unstructured":"Kunz R Vist G Oxman AD Randomisation to protect against selection bias in healthcare trials The Cochrane Database of Methodology Reviews"},{"key":"10.1002\/14651858.CD003620.pub2-BIB106|cit106","first-page":"1","article-title":"Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects","volume":"21","author":"Mulrow","year":"2000","journal-title":"Evidence Report\/Technology Assessment (Summary)"},{"key":"10.1002\/14651858.CD003620.pub2-BIB107|cit107","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1440-1746.2003.03037.x","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: an update","volume":"18","author":"Liaw","year":"2003","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD003620.pub2-BIB108|cit108","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-8278(00)80420-1","article-title":"Alcoholic liver disease: new insights in pathogenesis lead to new treatments","volume":"32","author":"Lieber","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB109|cit109","first-page":"345","article-title":"Beneficial effects of polyenylphosphatidylcholine (PPC) in alcoholic and non-alcoholic liver injury","volume-title":"Falk Symposium 121. Steatohepatitis (NASH and ASH)","volume":"121","author":"Lieber","year":"2001"},{"key":"10.1002\/14651858.CD003620.pub2-BIB110|cit110","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00004836-200310000-00013","article-title":"Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons","volume":"37","author":"Lieber","year":"2003","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD003620.pub2-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/01.ALC.0000093743.03049.80","article-title":"II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease","volume":"27","author":"Lieber","year":"2003","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"6","key":"10.1002\/14651858.CD003620.pub2-BIB112|cit112","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/jhep.2001.29401","article-title":"Chronic hepatitis B","volume":"34","author":"Lok","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD003620.pub2-BIB113|cit113","first-page":"410","article-title":"A review of plants used in the treatment of liver disease: part 1","volume":"3","author":"Luper","year":"1998","journal-title":"Alternative Medicine Review"},{"issue":"6","key":"10.1002\/14651858.CD003620.pub2-BIB114|cit114","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/095632029800900601","article-title":"Treatment of chronic viral hepatitis","volume":"9","author":"Main","year":"1998","journal-title":"Antiviral Chemistry and Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD003620.pub2-BIB115|cit115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0168-8278(87)80547-0","article-title":"Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease","volume":"4","author":"Marbet","year":"1987","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB116|cit116","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","article-title":"S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial","volume":"30","author":"Mato","year":"1999","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD003620.pub2-BIB117|cit117","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.1840140624","article-title":"Effect of parenteral amino acid supplementation in severe alcoholic hepatitis: a randomised controlled trial","volume":"14","author":"Mezey","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB118|cit118","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-anlyses","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003620.pub2-BIB119|cit119","first-page":"1185","article-title":"Alcoholic liver disease: natural history, diagnosis, clinical features, management, prognosis and prevention","volume-title":"Oxford Text Book of Clinical Hepatology","volume":"2","author":"Morgan","year":"1999"},{"key":"10.1002\/14651858.CD003620.pub2-BIB120|cit120","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jat.2550120613","article-title":"Silymarin protects against paracetamol-induced lipid peroxidation and liver damage","volume":"12","author":"Muriel","year":"1992","journal-title":"Journal of Applied Toxicology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB121|cit121","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1053\/jhep.2003.50118","article-title":"A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice","volume":"37","author":"Pelletier","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD003620.pub2-BIB122|cit122","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1440-1746.2000.02082.x","article-title":"Treatment of hepatitis C with interferon and ribavirin","volume":"15","author":"Pianko","year":"2000","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD003620.pub2-BIB123|cit123","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0002-9343(68)90111-3","article-title":"Duration of survival with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general managment of the disease","volume":"44","author":"Powell","year":"1968","journal-title":"American Journal of Medicine"},{"issue":"8921","key":"10.1002\/14651858.CD003620.pub2-BIB124|cit124","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0140-6736(94)91897-X","article-title":"Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case control study and simulated controls","volume":"344","author":"Poynard","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003620.pub2-BIB125|cit125","unstructured":"Rambaldi A Gluud C Colchicine for alcoholic and non-alcoholic liver cirrhosis and fibrosis The Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003620.pub2-BIB126|cit126","unstructured":"Rambaldi A Gluud C S-adenosyl-L-methionine for alcoholic liver diseases The Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003620.pub2-BIB127|cit127","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1572-0241.2002.05826.x","article-title":"Anabolic-androgenic steroids for alcoholic liver disease - a Cochrane Review","volume":"97","author":"Rambaldi","year":"2002","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB128|cit128","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1034\/j.1600-0676.2001.210606.x","article-title":"Propylthiouracil for alcoholic liver disease - Cochrane Review","volume":"21","author":"Rambaldi","year":"2002","journal-title":"Liver"},{"key":"10.1002\/14651858.CD003620.pub2-BIB129|cit129","unstructured":"Rambaldi A Jacobs BP Iaquinto G Gluud C Milk thistle for alcoholic and\/or hepatitis B or C virus liver diseases The Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD003620.pub2-BIB130|cit130","first-page":"806","article-title":"Stabilization of isolated rat liver plasma membranes by treatment in vitro with silymarin","volume":"24","author":"Ramellini","year":"1974","journal-title":"Arzneimittel Forschung"},{"key":"10.1002\/14651858.CD003620.pub2-BIB131|cit131","first-page":"1194","article-title":"The antihepatotoxic effect of silymarin on liver damage induced by carbon tetrachloride, d-galactosamine, and allyl alcohol","volume":"21","author":"Rauen","year":"1971","journal-title":"Arzneimittel Forschung"},{"key":"10.1002\/14651858.CD003620.pub2-BIB132|cit132","first-page":"148","article-title":"The antihepatotoxic effect of parenteral silymarin liver injury caused by CCL4 in the rat","volume":"23","author":"Rauen","year":"1973","journal-title":"Arzneimittel Forschung"},{"issue":"16","key":"10.1002\/14651858.CD003620.pub2-BIB133|cit133","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM196804182781602","article-title":"Alcohol-induced hepatic injury in non-alcoholic volunteers","volume":"278","author":"Rubin","year":"1968","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB134|cit134","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1572-0241.2000.01960.x","article-title":"Leucopenia is a side effect of combination therapy for hepatitis C infection","volume":"95","author":"Russo","year":"2000","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB135|cit135","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2165\/00003495-200161140-00003","article-title":"The use of sillymarin in the treatment of liver diseases","volume":"61","author":"Saller","year":"2001","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD003620.pub2-BIB136|cit136","first-page":"160","article-title":"The anti-hepatoxic effect of silymarin on thioacetamide-induced liver-damage","volume":"23","author":"Schriewer","year":"1973","journal-title":"Arzneimittelforschung"},{"issue":"5","key":"10.1002\/14651858.CD003620.pub2-BIB137|cit137","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of American Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD003620.pub2-BIB138|cit138","first-page":"249","article-title":"Protective effect of Legalon in workers exposed to organic solvent","volume":"45","author":"Szilard","year":"1988","journal-title":"Acta Medica Hungarica"},{"issue":"8397","key":"10.1002\/14651858.CD003620.pub2-BIB139|cit139","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(84)90295-2","article-title":"Prospective evaluation of alcohol abuse and alcoholic liver injury in as predictors of developement of cirrhosis","volume":"2","author":"S\u00f8rensen","year":"1984","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD003620.pub2-BIB140|cit140","first-page":"311","article-title":"Use of the Romanian product Silimarina\u00ae in the treatment of chronic liver diseases","volume":"26","author":"Tanasescu","year":"1988","journal-title":"Medecine Interne"},{"issue":"1","key":"10.1002\/14651858.CD003620.pub2-BIB141|cit141","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/hep.1840150115","article-title":"Treatment of severe alcoholic hepatitis by infusion of insulin\/glucagon: a multicenter sequential trial","volume":"15","author":"Trinchet","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB142|cit142","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0041-008X(79)90469-1","article-title":"Prevention of silybin of phalloidin-induced acute hepatotoxicity","volume":"51","author":"Tuchweber","year":"1979","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1002\/14651858.CD003620.pub2-BIB143|cit143","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/0006-291X(85)90243-8","article-title":"Inhibitory effect of the flavonoid silymarin on the erythrocyte hemolysis induced by phenylhydrazine","volume":"126","author":"Valenzuela","year":"1985","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1002\/14651858.CD003620.pub2-BIB144|cit144","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0197-2456(97)00150-5","article-title":"Do certain countries produce only positive results? A systematic review of controlled trials","volume":"19","author":"Vickers","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD003620.pub2-BIB145|cit145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00004836-200004000-00006","article-title":"Antiviral therapy of HBV - and HCV induced liver cirrhosis","volume":"30","author":"Zavaglia","year":"2000","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD003620.pub2-BIB146|cit146","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1111\/j.1572-0241.2005.00262.x","article-title":"Milk thistle for alcoholic and\/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials","volume":"100","author":"Rambaldi","year":"2005","journal-title":"American Journal of Gastroenterology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003620.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T00:00:00Z","timestamp":1192579200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003620.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:23:24Z","timestamp":1628529804000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003620.pub2"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,4,20]]},"references-count":146,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003620.pub2","relation":{},"subject":[],"published":{"date-parts":[[2005,4,20]]}}}